MMR status can be determined using microsatellite instability (MSI) testing and IHC. MSI testing analyzes the DNA of tumor tissues to detect instability at microsatellite regions, indicative of MMR deficiency. IHC, on the other hand, involves staining tissue sections with antibodies against MMR proteins to observe their presence or absence under a microscope.